Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Torguson

Showing results (281-290 of 378) with videos related to

Pageof 38
Sort By:
The American Journal of Cardiology|December 28, 2010
Effect of insurance type on adverse cardiac events after percutaneous coronary interventionMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
American Heart Journal|June 24, 2010
Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?Cédric Delhaye, Kohei Wakabayashi, Gabriel Maluenda, et al.
The American Journal of Cardiology|October 6, 2009
Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Itsik Ben-Dor, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2021
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and StatinsMick P L Renkens, Gary S Mintz, Rebecca Torguson, et al.
The American Journal of Cardiology|September 1, 2020
Procedural Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention During Normal Work Hours Versus Non-work HoursBrian C Case, Charan T Yerasi, Brian J Forrestal, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 26, 2009
A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease!Itsik Ben-Dor, Ron Waksman, Lowell F Satler, et al.
The American Journal of Cardiology|August 30, 2008
Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndromeLaurent Bonello, Axel De Labriolle, Probal Roy, et al.
The American Journal of Cardiology|March 3, 2015
Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivityThibault Lhermusier, Michael J Lipinski, Udaya S Tantry, et al.
Lancet (London, England)|October 27, 2004
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyEugène P McFadden, Eugenio Stabile, Evelyn Regar, et al.
American Heart Journal|December 5, 2009
The clinical significance of hematocrit values before and after percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Sara D Collins, et al.
Pageof 38

Showing results (281-290 of 378) with videos related to

Sort By:
Pageof 38
The American Journal of Cardiology|December 28, 2010
Effect of insurance type on adverse cardiac events after percutaneous coronary interventionMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
American Heart Journal|June 24, 2010
Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?Cédric Delhaye, Kohei Wakabayashi, Gabriel Maluenda, et al.
The American Journal of Cardiology|October 6, 2009
Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Itsik Ben-Dor, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2021
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and StatinsMick P L Renkens, Gary S Mintz, Rebecca Torguson, et al.
The American Journal of Cardiology|September 1, 2020
Procedural Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention During Normal Work Hours Versus Non-work HoursBrian C Case, Charan T Yerasi, Brian J Forrestal, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 26, 2009
A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease!Itsik Ben-Dor, Ron Waksman, Lowell F Satler, et al.
The American Journal of Cardiology|August 30, 2008
Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndromeLaurent Bonello, Axel De Labriolle, Probal Roy, et al.
The American Journal of Cardiology|March 3, 2015
Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivityThibault Lhermusier, Michael J Lipinski, Udaya S Tantry, et al.
Lancet (London, England)|October 27, 2004
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyEugène P McFadden, Eugenio Stabile, Evelyn Regar, et al.
American Heart Journal|December 5, 2009
The clinical significance of hematocrit values before and after percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Sara D Collins, et al.
Pageof 38